Clopidogrel hydrogen sulfate NEW
| Price | $30 | $40 | $50 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-04-28 |
Product Details
| Product Name: Clopidogrel hydrogen sulfate | CAS No.: 120202-66-6 |
| Purity: 99.79% | Supply Ability: 10g |
| Release date: 2025/04/28 |
Product Introduction
Bioactivity
| Name | Clopidogrel hydrogen sulfate |
| Description | Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation. |
| In vitro | In a rat model of ulcer margins, daily administration of Clopidogrel (2 mg and 10 mg/kg) significantly reduced the proliferation of gastric epithelial cells induced by ulcers, as well as the expression of the EGF receptor and phosphorylated extracellular signal-regulated kinase. In rats with congestive heart failure, Clopidogrel enhanced the phosphorylation of AKT and eNOS, thereby improving vascular endothelial function and the bioavailability of nitric oxide. |
| In vivo | In RGM-1 cells, Clopidogrel (1 μM) inhibits the epidermal growth factor-induced activation of epidermal growth factor receptor, PERK expression, and cellular proliferation. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 55 mg/mL (130.98 mM), Sonication is recommended. |
| Keywords | P2YReceptor | P2Y Receptor | P2Y | Cytochrome P450 | CYP2C19 | CYP2B6 | clot | Clopidogrel hydrogen | Clopidogrel Bisulfate |
| Inhibitors Related | Tebuconazole | 1-Ethynylnaphthalene | Diflubenzuron | Apigenin | Fenofibrate | 1-Aminobenzotriazole | Methoxsalen | Uridine-5'-diphosphate disodium salt | Naringin | Naringenin | Tauroursodeoxycholate | Ticagrelor |
| Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $30.00/25mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-07-15 | |
| $30.00/25mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-07-15 | |
| $80.00/1KG |
Shandong Xuhuang New material CoLTD
|
2025-02-21 | ||
| $9.90/1KG |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-10-31 | |
| $10.00/1kg |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-15 | |
| $0.00/1kg |
VIP2Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-26 | |
| $0.00/1Kg |
airuikechemical co., ltd.
|
2024-03-29 | ||
| $50.00/1kg |
VIP6Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-21 | |
| $0.00/25KG |
VIP6Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2023-08-28 | |
| $200.00/1kg |
Henan Bao Enluo International TradeCo.，LTD
|
2023-07-28 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY